Morgan Stanley Sees LifePoint Hospitals as Riding Medicaid Expansion in 2014
In a report published Tuesday, Morgan Stanley analyst Andrew Schenker reiterated an Equal-Weight rating on LifePoint Hospitals (NASDAQ: LPNT).
In the report, Morgan Stanley noted, “LPNT expects 2014 Adj. EBITDA of $560M to $590M inclusive of reform which implies growth of 4.3% to 9.9% Y/Y. Guidance compares with MS estimates of $582M and consensus of $585M. Adj. EPS is expected to come in between $2.38 to $2.78 per share, excluding a newly authorized $150M repurchase program set to begin post completion of the current program. We note MS estimate of $2.71 assumes $75M of the new program is completed in 2014.”
LifePoint Hospitals closed on Friday at $48.46.
Latest Ratings for LPNT
|Sep 2014||Deutsche Bank||Maintains||Buy|
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.